Abstract
SummaryBackgroundGlobally, an estimated 15·6 million people inject drugs. We aimed to investigate global variation in the age profile of people who inject drugs (PWID), identify country-level factors associated with age of PWID, and assess the association between injecting drug use (IDU) in young people and rates of injecting and sexual risk behaviours at the country level.MethodsWe derived data from a previously published global systematic review done in April, 2016 (and updated in June, 2017) on the percentage of young PWID, duration of IDU, average age of PWID, average age at IDU initiation, and the percentage of PWID reporting sexual and injecting risk behaviours. We also derived national development indicators from World Bank data. We estimated the percentage of young PWID for each country, using a random-effects meta-analysis (DerSimonian-Laird methodology) and generated pooled regional and global estimates for all indicators of IDU in young people. We used univariable and multivariable generalised linear models to test for associations between the age indicators and country urban population growth, youth unemployment percentage, the percentage of PWID who are female, the percentage of the general population aged 15–24 years, Gini coefficient, opioid substitution therapy coverage (per PWID per year), gross domestic product (GDP) per capita (US$1000), and sexual and injecting risk behaviours.FindingsIn the original systematic review, data on age of PWID was reported in 741 studies across 93 countries. Globally, 25·3% (95% uncertainty interval [UI] 19·6–31·8) of PWID were aged 25 years or younger. The highest percentage of young PWID resided in eastern Europe (43·4%, 95% UI 39·4–47·4), and the lowest percentage resided in the Middle East and north Africa (6·9%, 5·1–8·8). At the country level, in multivariable analysis higher GDP was associated with longer median injecting duration (0·11 years per $1000 GDP increase, 95% CI 0·04–0·18; p=0·002), and older median age of PWID (0·13 years per $1000 increase, 0·06–0·20; p<0·0001). Urban population growth was associated with higher age at IDU initiation (1·40 years per annual percentage change, 0·41–2·40). No associations were identified between indicators of IDU in young people and youth unemployment, Gini coefficient, or opioid substitution therapy coverage provision at the country level. No associations were identified between injecting and sexual risk behaviours and age of PWID.InterpretationVariation in the age profile of PWID was associated with GDP and urbanisation. Regions with the highest prevalence of young PWID (aged ≤25 years) had low coverage of interventions to prevent the spread of blood-borne viruses. Data quality highlights the need for improvements in monitoring of PWID populations.FundingAustralian National Drug and Alcohol Research Centre, Australian National Health and Medical Research Council, Open Society Foundation, WHO, the Global Fund, UNAIDS, National Institute for Health Research Health Protection Research Unit for Evaluation of Interventions, Wellcome Trust.
Highlights
An estimated 15·6 million people aged 15–64 years inject drugs (95% uncertainty interval [UI] 10·2–23·7).[1]
Evidence before this study In our 2017 systematic review, we identified wide country-level variation in the percentage of young people who inject drugs (PWID), which is a concern since young age of onset of injecting drug use (IDU) is associated with greater risk of overdose, faster progression to regular heroin use, and lower uptake of drug treatment
The results provide a compelling argument that growth and development might have implications for periods of epidemic drug use, and for necessary provision of measures to prevent the spread of blood-borne viruses
Summary
An estimated 15·6 million people aged 15–64 years inject drugs (95% uncertainty interval [UI] 10·2–23·7).[1] Injecting drug use (IDU) is of high public health impor tance because of the associated elevated risks of overdose, drug dependence, and blood-borne virus transm ission.[2] Subsequently, IDU is an important contributor to the global burden of disease.[3]. Younger age of onset of IDU is associated with overdose,[4] faster progression to regular heroin use,[5] and lower treatment uptake.[6] Young people who inject drugs (PWID) have been found to be more likely to share needles and syringes[7] and can be at high risk for engagement in sexual behaviour, facilitating the spread of blood-borne viruses.[8] Preventing the uptake of IDU among young people presents an opportunity to reduce the spread of these viruses to new generations and reduce the associated health-care burden
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
